Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1982 1
1983 5
1984 1
1985 1
1986 4
1987 1
1988 1
1989 2
1990 1
1991 3
1996 1
1997 2
1998 1
2000 1
2002 1
2003 1
2004 2
2005 1
2006 2
2007 2
2008 1
2010 2
2011 3
2015 1
2016 3
2017 3
2019 2
2020 3
2021 5
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and MET.
Neijssen J, Cardoso RMF, Chevalier KM, Wiegman L, Valerius T, Anderson GM, Moores SL, Schuurman J, Parren PWHI, Strohl WR, Chiu ML. Neijssen J, et al. Among authors: moores sl. J Biol Chem. 2021 Jan-Jun;296:100641. doi: 10.1016/j.jbc.2021.100641. Epub 2021 Apr 8. J Biol Chem. 2021. PMID: 33839159 Free PMC article.
Amivantamab, an Epidermal Growth Factor Receptor (EGFR) and Mesenchymal-epithelial Transition Factor (MET) Bispecific Antibody, Designed to Enable Multiple Mechanisms of Action and Broad Clinical Applications.
Cho BC, Simi A, Sabari J, Vijayaraghavan S, Moores S, Spira A. Cho BC, et al. Among authors: moores s. Clin Lung Cancer. 2023 Mar;24(2):89-97. doi: 10.1016/j.cllc.2022.11.004. Epub 2022 Nov 11. Clin Lung Cancer. 2023. PMID: 36481319 Free article. Review.
Amivantamab (JNJ-61186372), an Fc Enhanced EGFR/cMet Bispecific Antibody, Induces Receptor Downmodulation and Antitumor Activity by Monocyte/Macrophage Trogocytosis.
Vijayaraghavan S, Lipfert L, Chevalier K, Bushey BS, Henley B, Lenhart R, Sendecki J, Beqiri M, Millar HJ, Packman K, Lorenzi MV, Laquerre S, Moores SL. Vijayaraghavan S, et al. Among authors: moores sl. Mol Cancer Ther. 2020 Oct;19(10):2044-2056. doi: 10.1158/1535-7163.MCT-20-0071. Epub 2020 Aug 3. Mol Cancer Ther. 2020. PMID: 32747419
Regulation of AMPA receptor trafficking by secreted protein factors.
Rennich BJ, Luth ES, Moores S, Juo P. Rennich BJ, et al. Among authors: moores s. Front Cell Neurosci. 2023 Nov 27;17:1271169. doi: 10.3389/fncel.2023.1271169. eCollection 2023. Front Cell Neurosci. 2023. PMID: 38089145 Free PMC article. Review.
Radiation effects in the lung.
Coggle JE, Lambert BE, Moores SR. Coggle JE, et al. Among authors: moores sr. Environ Health Perspect. 1986 Dec;70:261-91. doi: 10.1289/ehp.8670261. Environ Health Perspect. 1986. PMID: 3549278 Free PMC article. Review.
Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical Trial.
Martinez FJ, Yow E, Flaherty KR, Snyder LD, Durheim MT, Wisniewski SR, Sciurba FC, Raghu G, Brooks MM, Kim DY, Dilling DF, Criner GJ, Kim H, Belloli EA, Nambiar AM, Scholand MB, Anstrom KJ, Noth I; CleanUP-IPF Investigators of the Pulmonary Trials Cooperative. Martinez FJ, et al. JAMA. 2021 May 11;325(18):1841-1851. doi: 10.1001/jama.2021.4956. JAMA. 2021. PMID: 33974018 Free PMC article. Clinical Trial.
Loss of SNORA73 reprograms cellular metabolism and protects against steatohepatitis.
Sletten AC, Davidson JW, Yagabasan B, Moores S, Schwaiger-Haber M, Fujiwara H, Gale S, Jiang X, Sidhu R, Gelman SJ, Zhao S, Patti GJ, Ory DS, Schaffer JE. Sletten AC, et al. Among authors: moores s. Nat Commun. 2021 Sep 1;12(1):5214. doi: 10.1038/s41467-021-25457-y. Nat Commun. 2021. PMID: 34471131 Free PMC article.
56 results